(Q84133192)

English

Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer

scientific article published on 01 December 2011

In more languages

default values for all languages

No label defined

No description defined

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

title

Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

author name string

Yan Feng

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

Patrick C Ma

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

publication date

1 December 2011

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

1 reference

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

volume

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

page(s)

550-554

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

Identifiers

DOI

10.1158/2159-8290.CD-11-0289

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

retrieved

1 February 2020

PubMed publication ID

22586678

1 reference

stated in

Europe PubMed Central

PubMed publication ID

22586678

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22586678%20AND%20SRC:MED&resulttype=core&format=json

(Q84133192)

Anti-MET targeted therapy has come of age: the first durable complete response with MetMAb in metastatic gastric cancer

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)